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Primary leiomyosarcomas of the thyroid gland are extremely rare. we report a case of a 72 year-old women with a
painful growing mass of the left neck with skin fistula. The patient underwent a lobectomy. The tumor histology
showed spindle-shaped cells arranged in interlacing fascicles that expressed desmine and Hcaldesmone, but were
negative for cytokeratins and thyroglobulin. Total body CT scan didnt show any other tumor. The patient died two
months after surgery. Primary thyroid leiomyosarcoma may be mistaken for other tumors, such as anaplastic or
medullary carcinomas. Therefore, the diagnosis is difficult and requires numerous clinical, radiological, and
pathological investigations.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1917621950869224
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Leiomyosarcomas are commonly seen in the pelvis, the
gastrointestinal tract and the retroperitoneum. They ac-
count for 6% of the head and neck tumors. Sarcomas are
thought to originate from the wall of blood vessels [1].
Primary leiomyosarcomas of the thyroid gland are
extremely rare. To the best of our knowledge, only 18
cases have been reported around the world. Immunohis-
tochemistry showing a smooth muscle-specific antigen is
helpful in establishing the diagnosis. Surgical excision is
the primary treatment of choice. Survival rate is low and
approximately half of the patients die within a short
period of time after the diagnosis. We report this new
case in the aim of shedding more light on the primary
leiomyosarcoma of the thyroid and the challenges in
making the diagnosis and the differential diagnosis with
anaplastic and medullary carcinomas.Case report
We present a case of a 72 year-old woman with a rapidly
growing neck mass over a period of two months. Her* Correspondence: bennaniamal@gmail.com
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reproduction in any medium, provided the orpast medical history includes a multinodular goiter diag-
nosed two years ago with no follow-up.
At the physical exam we found a painful mass of the left
neck with fistulae to the skin. She is clinically euthyroid
with normal plasma level of thyroid stimulating hormones.
A total body scan didn’t show any other mass.
The patient underwent a surgical exploration. There
was a hard, irregular tumor of the whole left lobe of the
thyroid gland, which was attached to the sterno-thyroidian
muscle and the left cervical pedicle. A left lobectomy was
realized. As the tumor largely invaded the surrounding tis-
sues, a curative operation seemed impossible.
The resected lobe measured 8.5 cm in the largest dimen-
sion; there is a multinodular appearance with a yellowish
nodule measuring 5 cm in diameter. On histology, the
lesion was focally well defined, but unencapsulated and
was composed of interlacing fascicles of atypical spindle
and epithelioid cells (Figure 1). These cells had an abun-
dant eosinophilic cytoplasm and a hyperchromatic blunt-
ended and cigar shaped nuclei with marked anisocaryosis
and high mitotic ratio (Figure 2). The stroma was scant,
essentially composed of capillaries with rare lymphocytes.
Some areas of necrosis were found.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The tumor is compactly cellular and is composed of spindle-shaped (hematoxylin-eosin-safran × 10).
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chyma with some non tumoral thyroid follicles trapped
into the tumor (Figure 3).
Undifferentiated thyroid carcinoma was suspected. The
immunohistochemical study with cytokeratin was negative
(Figure 4). Secondary immunohistochemical stains showed
positive diffusion for Hcaldesmone (Figure 5), and focal
positivity for desmine ( Figure 6) in the spindle cells all the
other stains performed (chromogranine, synaptophysine,
TTF1, estrogen receptor) were negative (Figure 7, Figure 8,
Figure 9).Figure 2 Nuclear cigarshaped nuclei with pleomorphism and mitosis,Discussion
Thyroid tumors are the most common endocrine tumors
in the United States, and about 40% of the population be-
tween 30 and 60 years-old have thyroid nodules, most of
which are benign [2]. A survey sponsored by the World
Health Organization (WHO) in 2010 revealed that there
are around 44,670 new cases and 1,690 deaths caused by
Thyroid carcinoma every year [3]. Papillary carcinoma
of the thyroid (PTC) is the commonest thyroid cancer
[4], while follicular thyroid carcinoma (FTC) accounts for
10 -17% of clinically evident thyroid malignancies [5].(hematoxylin-eosin-safran × 40).
Figure 3 The tumor often invades the surrounding thyroidian parenchyma with some non tumoral thyroid follicles trapped into the
tumor (×5).
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ceedingly rare and accounts for 0.014% of 28 630 thyroid
tumors in one series [6]. It occurred in older patients
with a mean age of 67 years with a predominance of
women, though one pediatric case of a 6-year-old boy
had been reported [7]. Patients often complained of an
enlarging cervical mass with Obstructive symptoms.
Most reports in the literature showed that the thyroid
function test is often normal. Thyroid scans can show aFigure 4 Immunohistochemical study with cytokeratin which was negcold nodule or an enlarged gland with areas of increased
and decreased uptake of radioactive iodine. Ultrasounds
show an ill-defined or well-defined hypoechogenic mass, a
solid partially cystic nodule , or a calcified nodule. At com-
puted tomography, the tumor presents as a low-density
mass with dense calcification and necrotic portions. In
addition, computed tomography sometimes shows a direct
tumoral invasion of the adjacent structures. In the current
case, the patient had clinically a locoregional extension.ative.
Figure 5 The tumor cells are stained with anti–hcaldesmone.
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replace one thyroid lobe or presents as an irregularly
outlined or a well-demarcated intrathyroidian nodule.
Cut surfaces show a pinkish, yellowish, white, fascicular
or homogenous, unencapsulated nodule with necrosis or
cystic degeneration. Histologicaly, the tumor is composed
of interlacing fascicles or bundles of eosinophilic spindle
cells with normochromatic to hyperchromatic, blunt-
ended, and cigar shaped nuclei, generally centrally located
within the cell. Mitoses are occasional to frequent. Variable
levels of cellular and nuclear pleomorphism are present.
Areas of hemorrhage, hyalinization, myxoid changes, andFigure 6 The tumor cells are stained with anti–desmine.necrosis may be found with occasional calcifications.The
tumor often invades the surrounding thyroidian paren-
chyma. Vascular invasion can be seen. Tumor cells are
stained with vimentin, (alpha-) smooth muscle actin, and
muscle-specific actin with a variable expression of desmin.
Cytokeratin, thyroglobulin, calcitonin, protein S100, and
chromogranin are never expressed.
The diagnosis of primary leiomyosarcomas of the thy-
roid gland requires particular prudence, because they are
often ill-defined, and invade the thyroid capsule and the
adjacent cervical structures. It seems important to exclude
a direct extension to the thyroid gland by a non thyroidian
Figure 7 There is no positivity for estrogen receptor.
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head and neck sarcomas are leiomyosarcomas, most com-
monly located at the scalp, paranasal sinuses, and jaws [8].
Surgical explorations as well as gross and microscopic
pathologic examinations are indispensable for a correct
identification of tumor origin. In our case, it showed a
tumor of the thyroid that was attached to the muscle
and cervical pedicle. Furthermore, it is important to ex-
clude thyroid metastases of a distant leiomyosarcoma. It
is believed that approximately 1% of thyroid cancers areFigure 8 There is no positivity for TTF1.metastases to the thyroid gland. In autopsy series, thy-
roid metastases have been found to occur in up to 24%
of patients who died of cancer [9]. Thus, only clinical
examination and appropriate imaging studies will help
in making the diagnosis. In our case, both physical exam
and total body scan didn’t show any other tumor. More-
over, more features were in favor of primitive lesion: it
is a solitary lesion (all the few cases of metastatic
leiomyosarcoma reported in literature presented clinic-
ally with multiple metastasis at lungs and bones), and it
Figure 9 There is no positivity for chromogranine or synaptophysine.
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surgery).
The main differential pathologic diagnoses includes un-
differentiated (anaplastic) thyroid carcinomas (UTCs), soli-
tary fibrous tumors, spindle cell tumors with thymus-like
differentiation, medullary carcinoma and other sarcomas.
Undifferentiated (anaplastic) thyroid carcinomas may dis-
play a very polymorphic microscopic features, including
spindle cells that can mimic the microscopic appearance
of fibrosarcoma, leiomyosarcoma, or malignant fibrous
histiocytoma. Epithelial markers can be missing in approxi-
mately 20% of cases [10] and even more often in spindle
cell sarcomatoid UTCs. Vimentin is also expressed in more
than 50% of UTCs [11]. Desmin and muscle-specific actin,
which are good markers of leiomyosarcomas, are never
expressed in UTCs [11]. Solitary fibrous tumors are pre-
dominantly composed of spindle cells, with various ar-
rangement. It is usually positive for CD34, BCL2, CD99,
and vimentin. Spindle cell tumors with thymus-like differ-
entiation is in most case biphasic, composed of compact
interlacing, or reticulated highly cellular fascicles of spindle
cells and tubulopapillary glands. In immunohistochemistry,
both spindle cells and glandular cells are positive for
cytokeratins, and rarely the spindle cells exhibit staining
with some muscle markers. Medullary carcinoma can
mimic any tumor structurally and functionally [12]. It can
show variable microscopic features, including spindle cells.
In immunochemistry, tumor cells are positive for chromo-
granine A, synaptophysine, ACE and calcitonine.
The etiology of primary leiomyosarcomas of the thyroid
gland still remains unknown. No history of previous cer-
vical radiation exposure in such cases had been reported
till now. As it was observed that a blood vessel was thepoint of origin of a leiomyosarcoma of the thyroid gland
[13], the histogenesis of leiomyosarcoma may be from the
smooth muscle in the vascular walls.
In our case, the diagnosis of leiomyosarcoma was
made on the pathological, and immunohistochemical
features of the tumor, which were similar to those found
in the literature.
Despite surgical excision, most patients die after 1 to
51 months or get a metastatic disease: (lungs, lymph
nodes, liver, myocardium, kidney, pancreas, small bowel,
colon, peritoneum, brain, and bones) [14]. Two cases
have been reported, in which the patients were still alive
with no evidence of disease, with a follow-up of 15 and
25 months [15].Conclusion
In summary, primary leiomyosarcoma of the thyroid is
extremely rare. It is a challenging diagnosis to make due
to its differential diagnosis with anaplastic and medullary
carcinoma. But before making this diagnosis, it is im-
portant to exclude a metastasis to the thyroid gland of a
distant leiomyosarcoma or a thyroid extension of a non
thyroidian cervical leiomyosarcoma.Consent
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